AbbVie Inc.
MX ˙ BMV ˙ US00287Y1091
SecurityMX:ABBV / AbbVie Inc.
InstitutionNarus Financial Partners, LLC
Latest Disclosed Ownership2,309 shares
Latest Disclosed Value $ 502,184
Narus Financial Partners, LLC reports 9.74% increase in ownership of ABBV / AbbVie Inc.

On April 21, 2026 - Narus Financial Partners, LLC filed a 13F-HR form disclosing ownership of 2,309 shares of AbbVie Inc. (MX:ABBV) valued at $502,184 USD as of March 31, 2026. The entity filed a previous 13F-HR on February 9, 2026 disclosing 2,104 shares of AbbVie Inc.. This represents a change in shares of 9.74% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-21 2026-03-31 13F ABBVIE COM 00287Y109 2,309 205 9.74 502 4.58 0.1307
2026-02-09 2025-12-31 13F ABBVIE COM 00287Y109 2,104 9 0.43 481 -1.03 0.1324
2026-02-09 2025-09-30 13F/A-1 ABBVIE COM 00287Y109 2,095 75 3.71 485 29.68 0.1310
2025-12-29 2025-09-30 13F ABBVIE COM 00287Y109 1,629 -391 377 0.4015
2025-07-14 2025-06-30 13F ABBVIE COM 00287Y109 2,020 32 1.61 375 -10.10 0.1170
2025-04-30 2025-03-31 13F ABBVIE COM 00287Y109 1,988 401 25.27 417 47.52 0.1417
2025-01-23 2024-12-31 13F ABBVIE COM 00287Y109 1,587 -821 -34.09 282 -40.63 0.0954
2024-10-18 2024-09-30 13F ABBVIE COM 00287Y109 2,408 187 8.42 476 25.00 0.1705
2024-07-17 2024-06-30 13F ABBVIE COM 00287Y109 2,221 222 11.11 381 4.40 0.1535
2024-04-18 2024-03-31 13F ABBVIE COM 00287Y109 1,999 124 6.61 364 25.52 0.1554
2024-01-25 2023-12-31 13F ABBVIE COM 00287Y109 1,875 196 11.67 291 16.00 0.1400
2023-10-30 2023-09-30 13F ABBVIE COM 00287Y109 1,679 136 8.81 250 20.77 0.1284
2023-08-30 2023-06-30 13F ABBVIE COM 00287Y109 1,543 2 0.13 208 -15.51 0.1074
2023-06-27 2023-03-31 13F ABBVIE COM 00287Y109 1,541 0 0.00 246 -1.61 0.1332
2023-10-12 2022-12-31 13F ABBVIE COM 00287Y109 1,541 1,541 249 0.1438
2023-10-12 2022-06-30 13F ABBVIE COM 00287Y109 0 -1,420 -100.00 0 -100.00
2023-09-12 2022-03-31 13F ABBVIE COM 00287Y109 1,420 1,420 -43.47 230 3.14 0.1288
2024-03-07 2021-03-31 13F ABBVIE COM 00287Y109 0 0 0 0.0000
2024-05-14 2019-06-30 13F ABBVIE COM 00287Y109 0 -2,512 -100.00 0 -100.00
2017-11-15 2017-09-30 13F ABBVIE COM 00287Y109 2,512 2,512 223 0.1964
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.